Evidence map›Paper›PMID 37512564›Full record

ArticleMetabolites2023

Cycloartane Saponins from

Ivan Stambolov, Aleksandar Shkondrov, Olaf Kunert, Franz Bucar, Magdalena Kondeva-Burdina, Ilina Krasteva

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Metabolites, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
4.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Bioactive components and clinical potential ofFrontiers in pharmacology · 2025
    Review
  4. Pharmaceutical biology · 2024
    Article
  5. Effect of a Total Extract and Saponins fromInternational journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Ivan StambolovDepartment of Pharmacognosy, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav St., 1000 Sofia, Bulgaria.
Aleksandar ShkondrovDepartment of Pharmacognosy, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav St., 1000 Sofia, Bulgaria.ORCID 0000-0001-5091-6058
Olaf KunertDepartment of Pharmaceutical Chemistry, Institute of Pharmaceutical Sciences, University of Graz, Universitätsplatz 1, A-8010 Graz, Austria.ORCID 0000-0002-7091-5973
Franz BucarDepartment of Pharmacognosy, Institute of Pharmaceutical Sciences, University of Graz, Beethovenstrasse 8, A-8010 Graz, Austria.ORCID 0000-0002-7417-616X
Magdalena Kondeva-BurdinaLaboratory of Drug Metabolism and Drug Toxicity, Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav St., 1000 Sofia, Bulgaria.
Ilina KrastevaDepartment of Pharmacognosy, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav St., 1000 Sofia, Bulgaria.ORCID 0000-0001-8559-0369
Medical University of Sofia · BGUniversity of Graz · AT

Funding

European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria № BG-RRP-2.004-0004-C01
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antioxidant activitybrain microsomesbrain mitochondriabrain synaptosomescycloartane saponinshMAO-B-inhibitionisolationneuroprotectionstructural elucidation

Identifiers

PMID37512564
PMCPMC10385106
OpenAlexW4384825083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.